COVID-19 vaccine," BMRC director Mahmood-Uz-Jahan said.The BMRC official said the regulator kept in consideration “Bangladesh’s benefit" alongside prospect and safety issues of the vaccine, studying the advancement of the Sinovac’s research in China, while reviewing the ICDDR’B proposal."We have also reviewed the headway of Sinovac’s COVID-19 vaccine development process...we have found they made potential advancements though the trial is still underway in China," he said.Dhaka-based International Centre for Diarrheal Disease Research, Bangladesh (ICDR’B) had submitted a research protocol, seeking to carry out the study.Jahan, however, said the BMRC approval would require a subsequent endorsement from Directorate General of Health Services.